BEIJING (Reuters) – China’s capital Beijing will speed up global procurement of COVID-related drugs to relieve pressure from domestic shortages, and expedite clearance for inbound shipments, a Beijing pharmaceuticals official said at a press conference on Monday.
(Reporting by Beijing Newswroom; Editing by Toby Chopra)
